Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder

This study has been completed.
Information provided by (Responsible Party):
Novartis Identifier:
First received: April 27, 2007
Last updated: May 2, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 2, 2012